St. Jude Medical was founded in 1976 in St. Paul, Minnesota, as a pioneering manufacturer of bi-leaflet implantable mechanical heart valves. The company’s innovative heart valve design soon became the “gold standard” for mechanical heart valves.

Since the company’s first major acquisition of Pacesetter in 1994, St. Jude Medical has continued to grow into a global leader in cardiac and neurological device technology, broadening our product portfolio through internal development and strategic acquisitions.

Today, St. Jude Medical is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. The company now has four main technology platforms including atrial fibrillation, cardiac rhythm management, cardiovascular and neuromodulation. St. Jude Medical has been recognized by FORTUNE magazine as one of America’s Most Admired Companies for six consecutive years and in 2010 was named to the FORTUNE 500.